Trial intelligence / Profile preview

Pai-Neng-Da capsule for chronic aplastic anemia

ChiCTR1900028153Phase 3Completed

Sponsor
Jinhua People's Hospital
Start
Jul 2015
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of pai-neng-da in aplastic anemia (2 arms), sponsored by Jinhua People's Hospital. Primary endpoint: Clinical recovery rate. Started Jul 2015; status: completed.

02

Drugs

pai-neng-da
03

Conditions

aplastic anemia

Beyond the preview

Go deeper on ChiCTR1900028153.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900028153.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call